Literature DB >> 21208229

Atrial fibrillation ablation: "perpetual motion" of open irrigated tip catheters at 50 W is safe and improves outcomes.

Roger A Winkle1, R Hardwin Mead, Gregory Engel, Rob A Patrawala.   

Abstract

BACKGROUND: Point-by-point use of open irrigated tip catheters (OITCs) at 50 W increases atrial fibrillation (AF) ablation cure rates but also increases complications. We determined if constantly moving the OITC (perpetual motion) when using 50 W increases ablation cure rates without increasing complications.
METHODS: We evaluated procedural data, complications, and individual procedure cure rates (IPCRs) for AF ablation using closed tip catheters (CTC) versus OITC at 40, 45, and 50 W in 1,122 ablations. We used "perpetual motion" to move the OITC at 50 W every 3-10 seconds.
RESULTS: The OITC showed higher IPCR than CTC at 45 W (P = 0.012) and 50 W (P < 0.0005). For the OITC, IPCR increased from 44.6% to 60.7% as power increased from 40 to 50 W (P = 0.008). The OITC appeared superior to the CTC for all types of AF. For paroxysmal AF, increasing OITC power from 40 to 50 W provided no increase in IPCR (70.6% vs 71.2%, P = 0.827). For persistent AF, increasing power from 40 to 50 W increased IPCR from 34.5% to 59.5% (P = 0.001). Complications were similar for the CTC and the OITC at any power. The OITC at 50 W had shorter procedure, left atrial, and fluoroscopy times (P < 0.0005).
CONCLUSIONS: Increasing OITC power from 40 to 50 W increases IPCR with no increase in complications as long as the 50 W setting is done using "perpetual motion." The OITC 50 W power setting results in shorter procedure and fluoroscopy times and should be considered for AF ablations. ©2010, The Authors. Journal compilation ©2010 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21208229     DOI: 10.1111/j.1540-8159.2010.02990.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  14 in total

Review 1.  The Impact of Advances in Atrial Fibrillation Ablation Devices on the Incidence and Prevention of Complications.

Authors:  Fehmi Keçe; Katja Zeppenfeld; Serge A Trines
Journal:  Arrhythm Electrophysiol Rev       Date:  2018-08

2.  Feasibility and safety of pulmonary vein isolation by high-power short-duration radiofrequency application: short-term results of the POWER-FAST PILOT study.

Authors:  Sergio Castrejón-Castrejón; Marcel Martínez Cossiani; Marta Ortega Molina; Carlos Escobar; Consuelo Froilán Torres; Nerea Gonzalo Bada; Marta Díaz de la Torre; José Manuel Suárez Parga; José Luis López Sendón; José Luis Merino
Journal:  J Interv Card Electrophysiol       Date:  2019-11-12       Impact factor: 1.900

3.  Trends in atrial fibrillation ablation: have we maximized the current paradigms?

Authors:  Roger A Winkle; R Hardwin Mead; Gregory Engel; Melissa H Kong; Rob A Patrawala
Journal:  J Interv Card Electrophysiol       Date:  2012-02-28       Impact factor: 1.900

4.  Prior antiarrhythmic drug use and the outcome of atrial fibrillation ablation.

Authors:  Roger A Winkle; R Hardwin Mead; Gregory Engel; Melissa H Kong; Rob A Patrawala
Journal:  Europace       Date:  2012-02-06       Impact factor: 5.214

5.  Peri-procedural interrupted oral anticoagulation for atrial fibrillation ablation: comparison of aspirin, warfarin, dabigatran, and rivaroxaban.

Authors:  Roger A Winkle; R Hardwin Mead; Gregory Engel; Melissa H Kong; Rob A Patrawala
Journal:  Europace       Date:  2014-08-12       Impact factor: 5.214

6.  Atrial fibrillation ablation using very short duration 50 W ablations and contact force sensing catheters.

Authors:  Roger A Winkle; Ryan Moskovitz; R Hardwin Mead; Gregory Engel; Melissa H Kong; William Fleming; Jonathan Salcedo; Rob A Patrawala; John H Tranter; Isaac Shai
Journal:  J Interv Card Electrophysiol       Date:  2018-02-19       Impact factor: 1.900

7.  Physician-controlled costs: the choice of equipment used for atrial fibrillation ablation.

Authors:  Roger A Winkle; R Hardwin Mead; Gregory Engel; Melissa H Kong; Rob A Patrawala
Journal:  J Interv Card Electrophysiol       Date:  2013-03-14       Impact factor: 1.900

8.  Discontinuing anticoagulation following successful atrial fibrillation ablation in patients with prior strokes.

Authors:  Roger A Winkle; R Hardwin Mead; Gregory Engel; Melissa H Kong; Rob A Patrawala
Journal:  J Interv Card Electrophysiol       Date:  2013-10-08       Impact factor: 1.900

9.  The industrialization of ablation: a highly standardized and reproducible workflow for radiofrequency ablation of atrial fibrillation.

Authors:  Tom De Potter; Tina D Hunter; Lee Ming Boo; Sofia Chatzikyriakou; Teresa Strisciuglio; Etel Silva; Peter Geelen
Journal:  J Interv Card Electrophysiol       Date:  2019-10-17       Impact factor: 1.900

10.  Comparison of high-power short-duration and low-power long-duration radiofrequency ablation for treating atrial fibrillation: Systematic review and meta-analysis.

Authors:  Chao-Feng Chen; Jing Wu; Chao-Lun Jin; Mei-Jun Liu; Yi-Zhou Xu
Journal:  Clin Cardiol       Date:  2020-10-27       Impact factor: 2.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.